Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 1,011 | 156 | 840 |
| Samples | 371 | 97 | 270 |
| Peptides | 262 | 68 | 205 |
Function
FBXO41 · F-box protein 41
This gene encodes a member of the F-box protein family, which is characterized by an approximately 40 amino acid motif, the F-box. F-box proteins constitute one of the four subunits of the SCF ubiquitin protein ligase complex that plays a role in phosphorylation-dependent ubiquitination. F-box proteins are divided into three classes depending on the interaction substrate domain each contains in addition to the F-box motif: FBXW proteins contain WD-40 domains, FBXL proteins contain leucine-rich repeats, and FBXO proteins contain either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the FBXO class. [provided by RefSeq, Feb 2014].
Isoforms & Proteins
3 transcripts · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
Gene Properties
Recurrent Mutations
All 262 amino-acid changes on canonical ENST00000520530 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in FBXO41 · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in FBXO41 – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| T-Lymphoblastic Leukemia | 5/40 12% | 0/0 0% |
| Chronic Myelogenous Leukemia | 1/25 4% | 0/0 0% |
| Acute Monocytic Leukemia | 0/1 0% | 1/25 4% |
| Acute Myeloid Leukemia | 3/90 3% | 0/0 0% |
| Endometrial Carcinoma | 4/42 10% | 14/612 2% |
| Thymic Epithelial Tumor | 0/0 0% | 1/39 3% |
| Gastrointestinal Stromal Tumour | 0/0 0% | 3/133 2% |
| Glioblastoma | 2/98 2% | 0/0 0% |
| Oral Cavity Carcinoma | 1/54 2% | 0/0 0% |
| Non-Small Cell Lung Carcinoma | 15/304 5% | 16/1390 1% |
| Gastric Carcinoma | 4/74 5% | 28/1809 2% |
| Thyroid Gland Carcinoma | 0/45 0% | 25/1592 2% |
| Hodgkins Lymphoma | 0/16 0% | 2/122 2% |
| Mesothelioma | 3/62 5% | 0/165 0% |
| Melanoma | 4/210 2% | 23/1899 1% |
| Colorectal Carcinoma | 4/143 3% | 38/3239 1% |
| Other Solid Cancers | 3/94 3% | 15/1515 1% |
| Cervical Carcinoma | 0/35 0% | 5/422 1% |
| Germ Cell Tumour | 2/25 8% | 0/169 0% |
| Bladder Carcinoma | 1/58 2% | 9/956 1% |
| Neuroendocrine Tumour | 5/154 3% | 2/577 0% |
| Esophageal Carcinoma | 3/23 13% | 4/769 1% |
| Plasma Cell Myeloma | 2/44 5% | 1/305 0% |
| Squamous Cell Lung Carcinoma | 1/57 2% | 6/810 1% |
| Other Sarcomas | 3/69 4% | 3/699 0% |
| Esophageal Squamous Cell Carcinoma | 2/51 4% | 17/2550 1% |
| Medulloblastoma | 0/0 0% | 3/450 1% |
| Small Cell Lung Carcinoma | 0/9 0% | 5/752 1% |
| Non-Cancerous | 2/104 2% | 4/830 0% |
| Ewings Sarcoma | 1/63 2% | 1/262 0% |
Mutation Distribution
Where FBXO41 is mutated · all tissues, split by cell line vs tissue
How many mutations in FBXO41 were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
GTEx Expression
Median TPM across 54 healthy tissues
Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.
Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.
Scroll or drag the mini-axis below the chart to browse all tissues.
Mutations
All 1,011 mutations in FBXO41
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|